Eikon Therapeutics, Inc. Common Stock (EIKN) is a publicly traded the market company. As of May 21, 2026, EIKN trades at $10.79 with a market cap of $636.13M and a P/E ratio of -4.30. EIKN moved +0.19% today. Year to date, EIKN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $7.90 to $17.40. Analyst consensus is buy with an average price target of $25.20. Rallies surfaces EIKN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent EIKN insider activity includes Column Group IV GP, LP bought 1.44M, Column Group IV GP, LP bought 49.56K, Column Group IV GP, LP bought 630.88K, Foresite Capital Management IV, LLC bought 55.55K, and FRAZIER KENNETH C bought 111.11K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $10.79 |
| Market Cap | $636.13M |
| P/E Ratio | -4.30 |
| EPS | $-2.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.40 |
| 52-Week Low | $7.90 |
| Volume | 2.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.38M |
| Net Income | $-82.96M |
| Gross Margin | 0.00% |
5 analysts cover EIKN: 0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.20.